Equities

Nath Bio-Genes (I) Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NATHBIOGEN:NSI

Nath Bio-Genes (I) Ltd

Actions
Consumer Staples Food Producers
  • Price (INR)150.06
  • Today's Change1.06 / 0.71%
  • Shares traded6.45k
  • 1 Year change-0.98%
  • Beta1.2574
Data delayed at least 15 minutes, as of Feb 18 2026 09:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nath Bio-Genes (India) Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The Company’s product categories include oilseeds and fiber, field crops, vegetables, and plant nutrition. Its fiber and oil seeds include cotton and mustard. The Company's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, and others. Its field crops include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. The Company’s forage products include NUTRIMAX and NUTRIMAX GOLD. It has seed processing facilities and processing plants located in Maharashtra, Telangana, and Andhra Pradesh.

  • Revenue in INR (TTM)4.45bn
  • Net income in INR410.57m
  • Incorporated1993
  • Employees451.00
  • Location
    Nath Bio-Genes (I) LtdNath House, Nath Road, P.No.518MUMBAI 400020IndiaIND
  • Phone+91 2 222871001
  • Fax+91 2 222875652
  • Websitehttps://nathbiogenes.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nath Bio-Genes (I) Ltd4.45bn410.57m2.83bn451.006.90--6.230.634221.5422.62233.60--------9,877,525.00--2.49--3.4270.0264.459.226.41--3.46--18.719.715.45-2.57-5.23-13.34--
Sheetal Universal Ltd947.31m94.93m2.89bn--30.456.3724.423.058.298.2982.6939.601.214.872.88--12.10--20.80--24.33--10.02--1.216.520.3572---19.91--347.98------
Harrisons Malayalam Ltd5.29bn252.07m3.48bn7.18k13.81--10.720.658313.6513.65286.32--------736,207.20--4.09--7.3764.3751.554.773.69--1.24--0.005.285.82303.869.9619.89--
SKM Egg Products Export India Ltd6.99bn774.23m9.71bn227.0012.54--10.421.3914.7014.70132.70--------30,783,230.00--13.74--20.5532.6632.0611.099.03--7.82--9.59-29.009.72-59.4849.1237.0124.57
Data as of Feb 18 2026. Currency figures normalised to Nath Bio-Genes (I) Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.